|
|
|
| Join Cencora this May 14-15 for our inaugural ThinkLive Cell and Gene Therapy Virtual Summit. This event will bring together global and emerging company leaders, providers, and experts who are shaping the future of healthcare. With over 30 speakers, 10 live sessions, and 6 focus areas, this event will provide valuable insights into the latest trends and strategies driving commercial success in CGT. View the agenda and register today. |
|
|
|
|
A conversation with Chris Horan, chief technical operations officer, Artiva Biotherapeutics | We caught up with Horan to delve into the realm of natural killer cell therapies, centering on Artiva’s rich experiences and strategic approaches, particularly focusing on their flagship candidate, AlloNK. |
|
|
|
Dive into understanding both auto and allo and why you would also have the supplier or the vendor sign up to address problematic root causes with your batch-to-batch variability. |
|
|
|
| Partnering For Success In Oncolytic Virus Development | Article | By Michael Baker, FUJIFILM Diosynth Biotechnologies | Learn how to navigate decision-making at critical steps and find solutions to key challenges in process development and scale-up to expedite oncolytic virus programs. |
|
|
|
| Optimizing Autologous Cell Therapy Clinical Trials | e-book | By Karen Ivester, inSeption Group | Delve into four articles regarding dissecting the critical resources, processes, and key stakeholders essential for the successful completion of an ACT clinical trial. |
|
|
| In Focus: The C Of CDMO | Article | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | Examine the intricacies of a successful CDMO relationship and unearth how a collaborative approach built on shared goals and open communication can maximize the potential of your cell therapy program. |
|
|
|
| Pioneering Solutions That Turn Hope Into Reality | Webinar | Andelyn Biosciences | The number of AAV-mediated therapies in clinical trials continues to rise, increasing demand for doses. A scalable platform is crucial to ensure a seamless transfer from pre-clinical to commercial. |
|
|
|
|
| The Future of Biotechnology in Individualized Medicine conference will explore the ongoing evolution of genomics from a tool for diagnostic breakthroughs to a driver of revolutionary therapeutics. Organized jointly by the Scripps Research Translational Institute, Actio Biosciences, and Advancing Precision Medicine, attendees will hear from renowned leaders from across academia and industry speak on the most recent innovation and trends in genomic medicine. View the full agenda and register here. |
|
|
|
|
|
|
|
|
| Genome editing holds immense promise for treating genetic diseases, but off-target effects remain a significant concern. To ensure the safety and efficacy of genome editing therapies, researchers are developing various strategies to reduce off-target effects. Register today for the next Cell & Gene Live. Attendance is free thanks to the support of Bio-Techne. |
|
|
| Connect With Cell & Gene: |
|
|
|
